Dermata Therapeutics's total assets for Q3 2024 were $6.69M, an increase of 27.71% from the previous quarter. DRMA total liabilities were $1.95M for the fiscal quarter, a 1.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.